HYDROMORPHONE HYDROCHLORIDE
- Product NDC
- 71335-0723
- 11-digit product format
- 713350723
- Labeler code
- 71335
- Product ID
- 71335-0723_dd7057dd-4448-4f11-8c2d-6a1bfe0e1f50
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROMORPHONE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA205814
- Marketing category
- ANDA
- Marketing start
- 2016-05-17
- Substance
- HYDROMORPHONE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HYDROMORPHONE HYDROCHLORIDE
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| HYDROMORPHONE HYDROCHLORIDE | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L960UP2KRW |
| Rxcui | 897702 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 71335-0723-0 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-1 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-2 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-3 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-4 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-5 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-6 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-7 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-8 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-9 | 2024-08-20 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-0 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-1 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-4 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-5 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-7 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-8 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
| 71335-0723-9 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3774-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use HYDROMORPHONE HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for HYDROMORPHONE HYDROCHLORIDE TABLETS. HYDROMORPHONE HYDROCHLORIDE tablets, for oral use, C-II Initial U.S. Approval: January 1984 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71335-0723-0 | HYDROMORPHONE HYDROCHLORIDE | 90 in 1 BOTTLE | TABLET | 90 | | 6 |
| 71335-0723-1 | HYDROMORPHONE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | | 6 |
| 71335-0723-2 | HYDROMORPHONE HYDROCHLORIDE | 180 in 1 BOTTLE | TABLET | 180 | | 6 |
| 71335-0723-3 | HYDROMORPHONE HYDROCHLORIDE | 120 in 1 BOTTLE | TABLET | 120 | | 6 |
| 71335-0723-4 | HYDROMORPHONE HYDROCHLORIDE | 20 in 1 BOTTLE | TABLET | 20 | | 6 |
| 71335-0723-5 | HYDROMORPHONE HYDROCHLORIDE | 25 in 1 BOTTLE | TABLET | 25 | | 6 |
| 71335-0723-6 | HYDROMORPHONE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | | 6 |
| 71335-0723-7 | HYDROMORPHONE HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET | 60 | | 6 |
| 71335-0723-8 | HYDROMORPHONE HYDROCHLORIDE | 56 in 1 BOTTLE | TABLET | 56 | | 6 |
| 71335-0723-9 | HYDROMORPHONE HYDROCHLORIDE | 140 in 1 BOTTLE | TABLET | 140 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71335-0723 | HYDROMORPHONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 6 | Current NDC, Legacy NDC, 10 package rows | 20240822_29765ff0-3b1d-47da-953e-28bf0e6a56ef.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0723-0 | 71335072300 | 90 TABLET in 1 BOTTLE (71335-0723-0) | 90 tablet | 2018-04-16 | 0000-00-00 | No | No | Current |
| 71335-0723-1 | 71335072301 | 30 TABLET in 1 BOTTLE (71335-0723-1) | 30 tablet | 2018-03-08 | 0000-00-00 | No | No | Current |
| 71335-0723-2 | 71335072302 | 180 TABLET in 1 BOTTLE (71335-0723-2) | 180 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-3 | 71335072303 | 120 TABLET in 1 BOTTLE (71335-0723-3) | 120 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-4 | 71335072304 | 20 TABLET in 1 BOTTLE (71335-0723-4) | 20 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-5 | 71335072305 | 25 TABLET in 1 BOTTLE (71335-0723-5) | 25 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-6 | 71335072306 | 100 TABLET in 1 BOTTLE (71335-0723-6) | 100 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-7 | 71335072307 | 60 TABLET in 1 BOTTLE (71335-0723-7) | 60 tablet | 2018-04-16 | 0000-00-00 | No | No | Current |
| 71335-0723-8 | 71335072308 | 56 TABLET in 1 BOTTLE (71335-0723-8) | 56 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |
| 71335-0723-9 | 71335072309 | 140 TABLET in 1 BOTTLE (71335-0723-9) | 140 tablet | 2024-08-09 | 0000-00-00 | No | No | Current |